Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Congress-2020-1000x250

Neuroendocrine Tumours

Optimising NET Treatment: The Place of Radioligand Therapy

58-Optimising-NET-Treatment-The-Place-of-Radioligand-Therapy-AAA-Thumb

On Demand Session
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Virtual Congress 2020 Industry Sponsored Satellite Symposia Programme

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings